Candida auris‒Associated Hospitalizations, United States, 2017–2022

Using a large US hospital database, we describe 192 Candida auris‒associated hospitalizations during 2017–2022, including 38 (20%) C. auris bloodstream infections. Hospitalizations involved extensive concurrent conditions and healthcare use; estimated crude mortality rate was 34%. These findings und...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedict, Kaitlin, Forsberg, Kaitlin, Gold, Jeremy A.W., Baggs, James, Lyman, Meghan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310363/
https://www.ncbi.nlm.nih.gov/pubmed/37347923
http://dx.doi.org/10.3201/eid2907.230540
_version_ 1785066523043299328
author Benedict, Kaitlin
Forsberg, Kaitlin
Gold, Jeremy A.W.
Baggs, James
Lyman, Meghan
author_facet Benedict, Kaitlin
Forsberg, Kaitlin
Gold, Jeremy A.W.
Baggs, James
Lyman, Meghan
author_sort Benedict, Kaitlin
collection PubMed
description Using a large US hospital database, we describe 192 Candida auris‒associated hospitalizations during 2017–2022, including 38 (20%) C. auris bloodstream infections. Hospitalizations involved extensive concurrent conditions and healthcare use; estimated crude mortality rate was 34%. These findings underscore the continued need for public health surveillance and C. auris containment efforts.
format Online
Article
Text
id pubmed-10310363
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-103103632023-07-01 Candida auris‒Associated Hospitalizations, United States, 2017–2022 Benedict, Kaitlin Forsberg, Kaitlin Gold, Jeremy A.W. Baggs, James Lyman, Meghan Emerg Infect Dis Research Letter Using a large US hospital database, we describe 192 Candida auris‒associated hospitalizations during 2017–2022, including 38 (20%) C. auris bloodstream infections. Hospitalizations involved extensive concurrent conditions and healthcare use; estimated crude mortality rate was 34%. These findings underscore the continued need for public health surveillance and C. auris containment efforts. Centers for Disease Control and Prevention 2023-07 /pmc/articles/PMC10310363/ /pubmed/37347923 http://dx.doi.org/10.3201/eid2907.230540 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Benedict, Kaitlin
Forsberg, Kaitlin
Gold, Jeremy A.W.
Baggs, James
Lyman, Meghan
Candida auris‒Associated Hospitalizations, United States, 2017–2022
title Candida auris‒Associated Hospitalizations, United States, 2017–2022
title_full Candida auris‒Associated Hospitalizations, United States, 2017–2022
title_fullStr Candida auris‒Associated Hospitalizations, United States, 2017–2022
title_full_unstemmed Candida auris‒Associated Hospitalizations, United States, 2017–2022
title_short Candida auris‒Associated Hospitalizations, United States, 2017–2022
title_sort candida auris‒associated hospitalizations, united states, 2017–2022
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310363/
https://www.ncbi.nlm.nih.gov/pubmed/37347923
http://dx.doi.org/10.3201/eid2907.230540
work_keys_str_mv AT benedictkaitlin candidaaurisassociatedhospitalizationsunitedstates20172022
AT forsbergkaitlin candidaaurisassociatedhospitalizationsunitedstates20172022
AT goldjeremyaw candidaaurisassociatedhospitalizationsunitedstates20172022
AT baggsjames candidaaurisassociatedhospitalizationsunitedstates20172022
AT lymanmeghan candidaaurisassociatedhospitalizationsunitedstates20172022

Ejemplares similares